Department of Experimental Oncology, IEO, European Institute of Oncology, IRCCS, 20139 Milano (Mi), Italy.
Laboratory of cellular immunology, Humanitas Clinical and Research Center-IRCCS-, via Manzoni 56, 20089 Rozzano (Mi), Italy.
Int J Mol Sci. 2020 Jul 8;21(14):4825. doi: 10.3390/ijms21144825.
Intestinal macrophages are key players in the regulation of the oral tolerance, controlling gut homeostasis by discriminating innocuous antigens from harmful pathogens. Diet exerts a significant impact on human health, influencing the composition of gut microbiota and the developing of several non-communicable diseases, including cancer. Nutrients and microbiota are able to modify the profile of intestinal macrophages, shaping their key function in the maintenance of the gut homeostasis. Intestinal disease often occurs as a breakdown of this balance: defects in monocyte-macrophage differentiation, wrong dietary habits, alteration of microbiota composition, and impairment in the resolution of inflammation may contribute to the development of intestinal chronic inflammation and colorectal cancer. Accordingly, dietary interventions and macrophage-targeted therapies are emerging as innovative tools for the treatment of several intestinal pathologies. In this review, we will describe the delicate balance between diet, microbiota and intestinal macrophages in homeostasis and how the perturbation of this equilibrium may lead to the occurrence of inflammatory conditions in the gut. The understanding of the molecular pathways and dietary factors regulating the activity of intestinal macrophages might result in the identification of innovative targets for the treatments of intestinal pathologies.
肠道巨噬细胞是调节口服耐受的关键因素,通过区分无害抗原和有害病原体来控制肠道内稳态。饮食对人类健康有重大影响,可影响肠道微生物组的组成,并引发多种非传染性疾病,包括癌症。营养素和微生物组能够改变肠道巨噬细胞的特征,从而塑造其在维持肠道内稳态方面的关键功能。肠道疾病通常是这种平衡被打破的结果:单核细胞-巨噬细胞分化缺陷、不良的饮食习惯、微生物组组成的改变以及炎症消退受损,可能导致肠道慢性炎症和结直肠癌的发生。因此,饮食干预和针对巨噬细胞的治疗方法正成为治疗多种肠道疾病的创新工具。在这篇综述中,我们将描述饮食、微生物组和肠道巨噬细胞在维持内稳态中的微妙平衡,以及这种平衡的破坏如何导致肠道炎症的发生。了解调节肠道巨噬细胞活性的分子途径和饮食因素可能会为治疗肠道疾病确定新的靶点。